Skip to main content
. 2024 Jan 29;25(2):46. doi: 10.31083/j.rcm2502046

Table 4.

Relationship between glucose quintiles and 30-day MACEs in patients with STEMI and NSTEMI.

Glucose Quintiles 30-day MACEs
OR (95% CI), p-value
Model 1 Model 2 Model 3
Patients with NSTEMI
Q1 1.31 (0.83, 2.09) p = 0.251 1.31 (0.82, 2.09) p = 0.258 1.21 (0.73, 2.02) p = 0.452
Q2 reference reference reference
Q3 1.44 (0.91, 2.28) p = 0.121 1.34 (0.84, 2.14) p = 0.212 1.22 (0.73, 2.03) p = 0.442
Q4 1.04 (0.63, 1.70) p = 0.886 1.01 (0.62, 1.67) p = 0.955 0.85 (0.50, 1.47) p = 0.573
Q5 1.92 (1.24, 2.98) p = 0.004 1.83 (1.17, 2.85) p = 0.008 1.40 (0.84, 2.34) p = 0.191
Patients with STEMI
Q1 0.93 (0.63, 1.37) p = 0.703 0.91 (0.61, 1.35) p = 0.634 0.89 (0.58, 1.36) p = 0.584
Q2 reference reference reference
Q3 1.07 (0.75, 1.54) p = 0.712 1.06 (0.74, 1.54) p = 0.746 1.04 (0.69, 1.56) p = 0.848
Q4 1.55 (1.10, 2.19) p = 0.013 1.56 (1.09, 2.21) p = 0.014 1.47 (0.98, 2.20) p = 0.061
Q5 1.91 (1.37, 2.66) p < 0.001 2.02 (1.44, 2.84) p < 0.001 2.23 (1.48, 3.35) p < 0.001
p for interaction 0.064 0.054 0.036

Model 1: adjusted for none. Model 2: adjusted for intervention, age, sex and SBP. Model 3: adjusted for intervention, age, sex, SBP, weight, heart rate, HDL-C, LDL-C, TG, smoking or tobacco, diabetes, hypertension, PAD, Symptom onset to arrival, Prior TIA or stroke, cardiac arrest at admission, LVEF category, PCI, antiplatelet, beta blocker. MACEs, major adverse cardiovascular events; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; SBP, systolic blood pressure; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglyceride; PAD, peripheral artery disease; TIA, transient ischemic attack; LVEF, left ventricular ejection fraction; PCI, percutaneous coronary intervention; OR, odds ratio; CI, confidence interval.